Holen Sie sich die Stockscreener-App
6.9098
0.60%
-0.0302
Schlusskurs vom Vortag:
$6.94
Offen:
$6.8
24-Stunden-Volumen:
503.41K
Relative Volume:
0.30
Marktkapitalisierung:
$1.19B
Einnahmen:
$25.55M
Nettoeinkommen (Verlust:
$-341.97M
KGV:
-2.4678
EPS:
-2.8
Netto-Cashflow:
$-304.44M
1W Leistung:
-8.27%
1M Leistung:
+25.88%
6M Leistung:
+112.26%
1J Leistung:
+17.92%
1-Tages-Spanne:
$6.76
$7.035
1-Wochen-Bereich:
$6.64
$7.64
52-Wochen-Spanne:
$1.775
$7.64
Relay Therapeutics Inc Stock (RLAY) Company Profile
Firmenname
Relay Therapeutics Inc
Sektor
Branche
Telefon
617-370-8837
Adresse
60 HAMPSHIRE STREET, CAMBRIDGE
Vergleichen Sie RLAY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RLAY
Relay Therapeutics Inc
|
6.91 | 1.20B | 25.55M | -341.97M | -304.44M | -2.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.82 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
635.03 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
427.46 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
842.63 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
185.93 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-04 | Fortgesetzt | Guggenheim | Buy |
| 2025-04-17 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-09-10 | Fortgesetzt | Goldman | Buy |
| 2024-09-10 | Hochstufung | Jefferies | Hold → Buy |
| 2024-09-10 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-05-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2023-04-20 | Hochstufung | Jefferies | Underperform → Hold |
| 2023-04-19 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-04-13 | Eingeleitet | Raymond James | Outperform |
| 2023-02-03 | Eingeleitet | Oppenheimer | Outperform |
| 2022-09-30 | Eingeleitet | Barclays | Equal Weight |
| 2022-09-02 | Eingeleitet | Stifel | Buy |
| 2022-06-06 | Eingeleitet | Jefferies | Underperform |
| 2022-02-01 | Eingeleitet | Berenberg | Buy |
| 2021-07-21 | Eingeleitet | BofA Securities | Buy |
| 2020-12-15 | Bestätigt | H.C. Wainwright | Buy |
| 2020-12-08 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2020-11-05 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-08-10 | Eingeleitet | Cowen | Outperform |
| 2020-08-10 | Eingeleitet | Goldman | Buy |
| 2020-08-10 | Eingeleitet | Guggenheim | Buy |
| 2020-08-10 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Relay Therapeutics Inc Aktie (RLAY) Neueste Nachrichten
Why hedge funds are buying Relay Therapeutics Inc. stockJuly 2025 Institutional & Fast Momentum Stock Entry Tips - newser.com
How Relay Therapeutics Inc. stock compares to growth peersJuly 2025 Sentiment & Low Drawdown Momentum Trade Ideas - newser.com
Does Relay Therapeutics Inc. show high probability of reboundMarket Growth Summary & Verified Entry Point Detection - newser.com
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in November - Investing News Network
Relay Therapeutics (NASDAQ: RLAY) to join Guggenheim, Jefferies chats on Nov. 10 & 19 - Stock Titan
Published on: 2025-11-03 09:01:58 - newser.com
Has Relay Therapeutics Inc. found a price floorShort Setup & Capital Efficient Trade Techniques - newser.com
Published on: 2025-11-03 06:18:27 - newser.com
What machine learning models say about Relay Therapeutics Inc.Quarterly Investment Review & Weekly Breakout Stock Alerts - newser.com
Is Relay Therapeutics Inc. stock a top momentum play2025 Key Highlights & Detailed Earnings Play Alerts - newser.com
Published on: 2025-11-03 01:59:20 - newser.com
Backtesting results for Relay Therapeutics Inc. trading strategiesJuly 2025 Outlook & Long-Term Investment Growth Plans - newser.com
How to forecast Relay Therapeutics Inc. trends using time seriesPortfolio Risk Summary & Low Drawdown Trading Techniques - newser.com
Building trade automation scripts for Relay Therapeutics Inc.2025 Key Lessons & Daily Technical Forecast Reports - newser.com
How to use a screener to detect Relay Therapeutics Inc. breakouts2025 Stock Rankings & Weekly Watchlist of Top Performers - newser.com
Using Ichimoku Cloud for Relay Therapeutics Inc. technicalsMarket Sentiment Report & Daily Growth Stock Tips - newser.com
Published on: 2025-11-02 22:47:47 - newser.com
Why retail investors favor Relay Therapeutics Inc. stockJuly 2025 Sentiment & Entry Point Confirmation Alerts - newser.com
Regression analysis insights on Relay Therapeutics Inc. performanceShare Buyback & Consistent Return Strategy Ideas - newser.com
Relay Therapeutics Inc.’s volatility index tracking explained2025 Breakouts & Breakdowns & Consistent Income Trade Ideas - newser.com
Key metrics from Relay Therapeutics Inc.’s quarterly dataGap Up & Verified Entry Point Signals - newser.com
Analyzing recovery setups for Relay Therapeutics Inc. investorsJuly 2025 Fed Impact & High Yield Equity Trading Tips - newser.com
Relay Therapeutics (NASDAQ:RLAY) Insider Donald Bergstrom Sells 30,897 Shares - MarketBeat
Peter Rahmer Sells 21,394 Shares of Relay Therapeutics (NASDAQ:RLAY) Stock - MarketBeat
Relay Therapeutics (NASDAQ:RLAY) Insider Peter Rahmer Sells 19,135 Shares - MarketBeat
Insider Selling: Relay Therapeutics (NASDAQ:RLAY) CFO Sells 21,664 Shares of Stock - MarketBeat
What drives Relay Therapeutics Inc stock priceValue Traps to Avoid & Join 100,000+ Investors Already Learning - earlytimes.in
Finanzdaten der Relay Therapeutics Inc-Aktie (RLAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
Relay Therapeutics Inc-Aktie (RLAY) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Rahmer Peter | See remarks |
Oct 28 '25 |
Sale |
7.29 |
19,135 |
139,494 |
358,863 |
| Catinazzo Thomas | Chief Financial Officer |
Oct 28 '25 |
Sale |
7.29 |
21,664 |
157,931 |
313,631 |
| Bergstrom Donald A | President, R&D |
Oct 28 '25 |
Sale |
7.29 |
30,897 |
225,239 |
521,823 |
1.71%
0.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):